|
LOC221710 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.665600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.621400E-01 |
| Normal-vs-Stage2 |
1.427840E-01 |
| Normal-vs-Stage3 |
8.213700E-02 |
| Normal-vs-Stage4 |
6.833000E-01 |
| Stage1-vs-Stage2 |
1.647040E-01 |
| Stage1-vs-Stage3 |
6.420300E-02 |
| Stage1-vs-Stage4 |
8.421400E-01 |
| Stage2-vs-Stage3 |
7.298200E-01 |
| Stage2-vs-Stage4 |
2.781200E-01 |
| Stage3-vs-Stage4 |
2.822400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.500600E-01 |
| Normal-vs-AfricanAmerican |
2.307900E-02 |
| Normal-vs-Asian |
8.420600E-01 |
| Caucasian-vs-AfricanAmerican |
3.282000E-02 |
| Caucasian-vs-Asian |
9.524400E-01 |
| AfricanAmerican-vs-Asian |
3.620400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.973200E-01 |
| Normal-vs-Female |
5.846200E-01 |
| Male-vs-Female |
4.899600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.725600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.934000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.399400E-01 |
| Normal-vs-Age(81-100Yrs) |
6.692400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.563400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.424000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.528400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.395000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.764650E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.041000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.256800E-01 |
| Normal-vs-Grade 2 |
6.831800E-01 |
| Normal-vs-Grade 3 |
2.638400E-02 |
| Normal-vs-Grade 4 |
1.850770E-01 |
| Grade 1-vs-Grade 2 |
8.145000E-01 |
| Grade 1-vs-Grade 3 |
9.805700E-02 |
| Grade 1-vs-Grade 4 |
2.837000E-01 |
| Grade 2-vs-Grade 3 |
1.079760E-03 |
| Grade 2-vs-Grade 4 |
6.817600E-02 |
| Grade 3-vs-Grade 4 |
7.967600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.219800E-01 |
| Normal-vs-ccB subtype |
2.559400E-01 |
| ccA subtype-vs-ccB subtype |
5.276400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.941000E-01 |
| Normal-vs-N1 |
7.102400E-01 |
| N0-vs-N1 |
9.300000E-01 |
|
|
